title: Pentoxifylline (PTX) selectively potentiates cyclosporine (CsA)-mediated suppression of cell-mediated lymphocytotoxicity. Median-effect analysis for the drug dose reductions in PTX and CsA combination treatment.
authors.affiliation: Laboratories of Interferon and Cytokine Research, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
authors.forename: K S
authors.initials: KS
authors.lastname: Khabar
authors.forename: M
authors.initials: M
authors.lastname: Dzimiri
authors.forename: R S
authors.initials: RS
authors.lastname: Parhar
authors.forename: S
authors.initials: S
authors.lastname: Siddiqui
authors.forename: M
authors.initials: M
authors.lastname: Einspenner
authors.forename: A
authors.initials: A
authors.lastname: Al-Humaidan
authors.forename: S T
authors.initials: ST
authors.lastname: Al-Sediary
mesh_terms: D016572:Cyclosporine / Q000494:pharmacology*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects*; D004357:Drug Synergism; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology; D010431:Pentoxifylline / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*
chemical_list: D007166:Immunosuppressive Agents; D010726:Phosphodiesterase Inhibitors; D016572:Cyclosporine; D010431:Pentoxifylline